https://www.cnbctv18.com/healthcare/who-authorizes-emergency-use-of-novavaxs-updated-covid-vaccine-18425541.htm
0
0
39 words
0
Comments
Novavax missed out on the COVID-19 vaccine windfall, which benefited rivals, due to manufacturing issues that delayed its filing for approval during the peak of the pandemic.
You are the first to view
Create an account
or login to join the discussion